Health Care/Hospital

Sirtex Medical and China Grand Pharmaceutical announce SIR-Spheres® Y-90 resin microspheres milestone

SIR-Spheres® new drug application is accepted by the National Medical Products  Administration of China WOBURN, Mass., Nov. 26, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that Sirtex with the support of its shareh...

2020-11-26 01:17 1746

RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA

LUND, Sweden, Nov. 25, 2020 /PRNewswire/ -- RhoVac, a clinical stage company today announced that the American FDA has granted Fast Track Designation to the company's drug candidate, RV001. Fast Track Designation is granted to investigational drugs for expedited review by the FDA, to facilitate ...

2020-11-25 16:06 1326

Indonesia's Government to Help Improve the Welfare of Non-Civil Servant Educators and Educational Personnel Through Wage Subsidies

* Channeling a total of Rp 3.6 trillion in aid to two million people. * Beneficiaries include lecturers at state and private universities, teachers, as well as library, laboratory and administrative staff who all receive a lump sum ofRp 1.8 million each. JAKARTA, Indonesia, Nov. 25, 2020 /PRN...

2020-11-25 13:11 1657

Ascentage Pharma Announces First Patient Dosed in Europe in the Phase Ib/II Study of the Bcl-2 inhibitor APG-2575 in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

SUZHOU, China and ROCKVILLE, Md., Nov. 25, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a Phase Ib/II clinical ...

2020-11-25 08:27 2036

MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients

NYON, Switzerland, Nov. 25, 2020 /PRNewswire/ -- MedAlliance has announced completion of patient enrolment in theISABELLA Clinical Trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of dysfunctional AV fistulas in end-stage renal failure patients undergoing hemodialysis. SE...

2020-11-25 08:00 2189

Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Awardees of the Seoul Innovation QuickFire Challenge on Healthcare for the New Normal in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute

- Awardees DC Medical and deepmedi recognized for pioneering efforts leveraging data and health technologies to advance potentially life-saving ideas aimed at improving patient care during the COVID-19 pandemic and beyond. SEOUL, South Korea, Nov. 25, 2020 /PRNewswire/ -- Janssen Korea Ltd. and ...

2020-11-25 07:00 2547

RedHill Biopharma to Present at Evercore ISI HealthCONx and Piper Sandler Healthcare Conferences

TEL AVIV, Israel and RALEIGH, N.C., Nov. 25, 2020 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will present and participate at the following virtual conferen...

2020-11-25 07:00 2522

Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

BARCELONA, Spain, Nov. 25, 2020 /PRNewswire/ -- AlmirallShare , the open innovation platform of Almirall, S.A. (ALM),  announces two new collaborations with theUniversity of South Australia and the Fundació Institut de Recerca de ...

2020-11-25 06:00 5522

China Biologic Reports Financial Results for the Third Quarter of 2020

BEIJING, Nov. 24, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the third quarter of 2020. Third Quarter...

2020-11-25 05:30 11660

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021

HONG KONG, Nov. 25, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...

2020-11-25 05:16 12296

The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets

RDIF continues expanding existing agreements with international manufacturing partners to produce the vaccine for more than 500 million people in 2021 MOSCOW, Nov. 25, 2020 * The cost of one dose of the Sputnik V vaccine for international markets will be less than$10. Sputnik V is a two dose ...

2020-11-25 04:38 1283

PwC Actuarial Services Hails Aon's PathWise® Platform for IFRS 17 Reporting

LONDON, Nov. 24, 2020 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, today announces that professional services firm PwC has completed a successful review of Aon's PathWise® platform for re/insurer...

2020-11-24 23:00 11726

NaviFUS highlights clinical trial data and device capabilities at virtual International Focused Ultrasound Symposium

TAIPEI, Nov. 24, 2020 /PRNewswire/ -- The 7th International Focused Ultrasound Symposium organized by the U.S. Focused Ultrasound Foundation took place from 11/9 to 11/13 in virtual format this year due to theCOVID-19 epidemic. During the 5-day conference, participants presented and exchanged inf...

2020-11-24 22:26 1181

Second interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose

MOSCOW, Nov. 24, 2020 /PRNewswire/ -- * The efficacy of the Sputnik V vaccine is 91.4%, based on the second interim analysis of data obtained 28 days after administering the first dose (7 days after the second dose). * Calculation was based on the analysis of data on volunteers (n = 18,794) ...

2020-11-24 22:14 1329

World's Airports And Leading Airlines Join CommonTrust Network And Begin Roll-out Of CommonPass In December In Support Of Safer Border Reopening

* The World Economic Forum and The Commons Project Foundation welcome Airports Council International (ACI) World as a member of the CommonTrust Network * CommonTrust Network airlines JetBlue, Lufthansa, Swiss International Airlines, United Airlines, Virgin Atlantic to begin roll-out of Comm...

2020-11-24 22:09 1619

OliPass Announces Formation of Scientific Advisory Board of Pioneers in Sodium Ion Channellopathy and Pain

SEOUL, South Korea, Nov. 24, 2020 /PRNewswire/ -- OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced to commission a Scientific Advisory Board ("SAB") of key experts in sodium ion channelopathy and pain. The SAB will advise OliPass on th...

2020-11-24 22:00 1551

INSIGHTEC Announces MR-guided Focused Ultrasound to Treat Essential Tremor Received Funding by National Health Service (NHS) England

HAIFA, Israel and MIAMI, Nov. 24, 2020 /PRNewswire/ -- INSIGHTEC ®, a global healthcare company focused on the therapeutic power of acoustic energy, today announced that the National Health Service (NHS)England has approved funding for MR-guided Focused Ultrasound for ...

2020-11-24 19:00 1270

TUV Rheinland Named Mercer China Top Healthiest Workplace

SHANGHAI, Nov. 24, 2020 /PRNewswire/ -- On November 12th, 2020, the Mercer Health and Benefits Online Forum cum Mercer China Healthiest Workplace Awards Ceremony 2020-2021 was held atShanghai's Wanda Reign on the Bund, bringing together representatives from 250 companies on-site and more than 25,...

2020-11-24 18:28 2677

TOP 6 Beauty Trends of 2020 -- Revel in the most celebrated trends and product innovations unveiled in CosmoTrends

HONG KONG, Nov. 24, 2020 /PRNewswire/ -- In this time of great upheaval, it is critical to keep thinking forward. Cosmoprof Asia is pleased to present the latest CosmoTrends report curated by renowned global beauty trend forecasting agency BEAUTYSTREAMS. Products that made it to this online repor...

2020-11-24 18:07 2545

Pine Care Group announces its 2020 Interim Results

Core EBITDA surged 38.9%; net profit increased by 31% Highlights * An overage occupancy rate of 94.7%, compared to 93.5% for the same period in 2019 * Revenue increased by 13.4% to HK$120.9 million, was mainly driven by the combined effects of ramp-up in the occupancy rate of Pine Care Place...

2020-11-24 17:57 7053
1 ... 587588589590591592593 ... 805